{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:39:05Z","timestamp":1792478345724,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.trim.2026.102465","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:54:26Z","timestamp":1792079666000},"page":"102465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emerging stem cell strategies for neurodegenerative diseases"],"prefix":"10.1016","volume":"99","author":[{"given":"Marhaen","family":"Hardjo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfi","family":"Sophian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2026.102465_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biopha.2017.04.034","article-title":"Immunomodulatory effects of stem cells: therapeutic option for neurodegenerative disorders","volume":"91","author":"Caprnda","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.trim.2026.102465_bb0010","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1097\/PHM.0000000000000111","article-title":"Stem cells in the nervous system","volume":"93","author":"Maldonado-Soto","year":"2014","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.trim.2026.102465_bb0430","series-title":"Dementia (fact sheet)","author":"World Health Organization","year":"2026"},{"key":"10.1016\/j.trim.2026.102465_bb0435","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.trim.2026.102465_bb0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/26895293.2021.1967202","article-title":"Stem cell and its derivatives as drug delivery vehicles: an effective new strategy of drug delivery system","volume":"14","author":"Fu","year":"2021","journal-title":"All Life"},{"key":"10.1016\/j.trim.2026.102465_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020993","article-title":"Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases","volume":"25","author":"Velikic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0025","first-page":"3461","article-title":"Cell-derived exosome therapy: a novel approach to treat post-traumatic brain injury mediated neural injury","volume":"11","author":"Ghosh","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.trim.2026.102465_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.12688\/f1000research.9846.1","article-title":"Rejuvenating stem cells to restore muscle regeneration in aging","volume":"6","author":"Bengal","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.trim.2026.102465_bb0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ejn.14051","article-title":"Primary tissue for cellular brain repair in Parkinson's disease: promise, problems and the potential of biomaterials","volume":"49","author":"Moriarty","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.trim.2026.102465_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060707","article-title":"Current strategies and therapeutic applications of mesenchymal stem cell-based drug delivery","volume":"17","author":"Matsuzaka","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.trim.2026.102465_bb0440","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s12015-025-10893-w","article-title":"Engineering the future of regenerative medicines in gut health with stem cell-derived intestinal organoids","volume":"21","author":"Kumar","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.trim.2026.102465_bb0445","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12015-025-10985-7","article-title":"Stem cells to organoids: pioneering the future of regenerative therapies","volume":"22","author":"Kumar","year":"2026","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.trim.2026.102465_bb0450","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-025-04889-z","article-title":"Stem cells in organogenesis and regeneration","author":"Mim","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.trim.2026.102465_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.abb.2012.10.001","article-title":"Paracrine regulation of neural stem cells in the subependymal zone","volume":"534","author":"Porlan","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.trim.2026.102465_bb0050","first-page":"1996","article-title":"ADAM10 facilitates rapid neural stem cell cycling and proper positioning within the subventricular zone niche via JAMC\/RAP1Gap signaling","volume":"17","author":"McMillan","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.trim.2026.102465_bb0055","first-page":"92","article-title":"Research advances in mesenchymal stem cell-derived exosomes in treatment of brain injury","volume":"19","author":"Yue","year":"2017","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.trim.2026.102465_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/kjm2.12951","article-title":"Olfactory mucosa mesenchymal stem cell-derived exosomes protect against neuroinflammation after subarachnoid hemorrhage by activating mitophagy","volume":"41","author":"Wang","year":"2025","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0065","first-page":"1991","article-title":"Exosomes derived from bone marrow mesenchymal stem cells inhibit neuroinflammation after traumatic brain injury","volume":"17","author":"Wen","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.trim.2026.102465_bb0070","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1002\/jcp.30495","article-title":"Neuroinflammation: the next target of exosomal microRNAs derived from mesenchymal stem cells in the context of neurological disorders","volume":"236","author":"Hajinejad","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.trim.2026.102465_bb0075","first-page":"3175","article-title":"Effect of stem cell derived exosomes on repairing peripheral nerve injury","volume":"25","author":"Kang","year":"2021","journal-title":"Chin. J. Tissue Eng. Res."},{"key":"10.1016\/j.trim.2026.102465_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03409-1","article-title":"Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury","volume":"14","author":"Zhong","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.trim.2026.102465_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/sci\/8841129","article-title":"Exosome-loaded bioscaffolds for spinal cord injuries: a review","author":"Chen","year":"2025","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.trim.2026.102465_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.trim.2026.102465_bb0470","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-025-10940-6","article-title":"Development of a high-throughput morphological assay for evaluating mesenchymal stromal cell-derived extracellular vesicle modulation of brain pericyte secretory phenotype","author":"Campagna","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.trim.2026.102465_bb0090","doi-asserted-by":"crossref","first-page":"R274","DOI":"10.1093\/hmg\/ddaa167","article-title":"The role of the stem cell epigenome in normal aging and rejuvenative therapy","volume":"29","author":"Jayarajan","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.trim.2026.102465_bb0095","article-title":"The role and mechanism of mesenchymal stem cell-derived extracellular vesicles in the rejuvenation of aging tissues","author":"Wu","year":"2026","journal-title":"Chin. J. Geriatr."},{"key":"10.1016\/j.trim.2026.102465_bb0100","series-title":"Extracellular Vesicle: Biology and Translational Application","first-page":"123","article-title":"Extracellular vesicles in aging and age-related diseases","author":"Liu","year":"2024"},{"key":"10.1016\/j.trim.2026.102465_bb0105","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1111\/febs.12221","article-title":"Functional dysregulation of stem cells during aging: a focus on skeletal muscle stem cells","volume":"280","author":"Garc\u00eda-Prat","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.trim.2026.102465_bb0480","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nm.3464","article-title":"Rejuvenation of the muscle stem cell population restores strength to injured aged muscles","volume":"20","author":"Cosgrove","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","article-title":"Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis","volume":"198","author":"Crigler","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.trim.2026.102465_bb0115","first-page":"9368","article-title":"Comparing the effect of neurotrophic factor induced MSCs (BMSC and DPSC) on the expression of myelin proteins Nogo-a and OMgp in a glaucoma rat model","volume":"10","author":"Li","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0120","article-title":"Noncoding RNA in extracellular vesicles regulate differentiation of mesenchymal stem cells","volume":"2","author":"Yan","year":"2021","journal-title":"Front. Dent. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071450","article-title":"Mesenchymal stem\/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents","volume":"18","author":"B\u00f6rger","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0130","article-title":"Role of MSC-derived small extracellular vesicles in tissue repair and regeneration","volume":"10","author":"Aguiar Koga","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.trim.2026.102465_bb0135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2016.09.017","article-title":"Extracellular vesicles: immunomodulatory messengers in the context of tissue repair\/regeneration","volume":"98","author":"Silva","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0140","first-page":"1","article-title":"New paradigms in regenerative engineering: emerging role of extracellular vesicles paired with instructive biomaterials","volume":"46","author":"Swanson","year":"2022","journal-title":"Biocell"},{"key":"10.1016\/j.trim.2026.102465_bb0145","first-page":"1475","article-title":"Transplantation of fetal stem cells: a new horizon for treatment of degenerative diseases","volume":"44","author":"Razi","year":"2015","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.trim.2026.102465_bb0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/1574888X15666200311141731","article-title":"Stem cells: a review encompassing the literature with a special focus on the side-lined miraculous panacea; pre-morula stem cells","volume":"15","author":"Saini","year":"2020","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.trim.2026.102465_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-024-10793-5","article-title":"Evaluating strategies to assess the differentiation potential of human pluripotent stem cells: a review, analysis and call for innovation","volume":"21","author":"Smith","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.trim.2026.102465_bb0160","first-page":"124","article-title":"Mesenchymal stem cells in neurological disorders: insights from clinical trials","volume":"26","author":"Ara\u00fajo","year":"2025","journal-title":"Regen. Ther."},{"key":"10.1016\/j.trim.2026.102465_bb0165","article-title":"Research progress on the intervention of human umbilical cord mesenchymal stem cell in neurodegenerative disease","volume":"37","author":"Xu","year":"2026","journal-title":"China Pharm."},{"key":"10.1016\/j.trim.2026.102465_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-02032-8","article-title":"Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.trim.2026.102465_bb0175","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2217\/rme-2019-0119","article-title":"Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice","volume":"15","author":"Reyhani","year":"2020","journal-title":"Regen. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/ten.teb.2013.0664","article-title":"Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?","volume":"20","author":"El Omar","year":"2014","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.trim.2026.102465_bb0185","article-title":"Mesenchymal stem cells in treatment of spinal cord injury and amyotrophic lateral sclerosis","volume":"9","author":"Sykova","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.trim.2026.102465_bb0200","article-title":"Wharton's jelly mesenchymal stem cells (WJ-MSCs), a 'holy grail' in tissue bioengineering and reconstructive medicine","volume":"182","author":"G\u00f3rnicki","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.trim.2026.102465_bb0205","first-page":"1208","article-title":"Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells","volume":"96","author":"Tantrawatpan","year":"2013","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.trim.2026.102465_bb0210","first-page":"2991","article-title":"Characterization of stage-specific embryonic antigen-4 (SSEA-4)-positive very small embryonic-like stem cells isolated from human Wharton's jelly","volume":"10","author":"Li","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/sctm.17-0108","article-title":"Neurotrophically induced mesenchymal progenitor cells derived from induced pluripotent stem cells enhance neuritogenesis via neurotrophin and cytokine production","volume":"7","author":"Brick","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0375","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13770-025-00742-9","article-title":"Establishment of immune-evasive iPSCs from PBMCs using B2M knockout and CD47\/HLA-E overexpression","volume":"22","author":"Kim","year":"2025","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0380","first-page":"100","article-title":"Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockout","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0385","first-page":"1","article-title":"Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells","volume":"660","author":"Flahou","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.trim.2026.102465_bb0390","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trim.2026.102465_bb0190","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bpobgyn.2004.06.010","article-title":"Fetal stem cells","volume":"18","author":"O'Donoghue","year":"2004","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.trim.2026.102465_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-014-1926-5","article-title":"Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow","volume":"358","author":"Brown","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.trim.2026.102465_bb0465","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mus.27472","article-title":"A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis","volume":"65","author":"Cudkowicz","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.trim.2026.102465_bb0455","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.trim.2026.102465_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.trim.2026.102465_bb0220","article-title":"Cultivation of human neural progenitor cells in a 3-dimensional self-assembling peptide hydrogel","volume":"59","author":"Liedmann","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.trim.2026.102465_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-021-04047-7","article-title":"Bioengineered models of Parkinson's disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment","volume":"79","author":"Fiore","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0230","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/acsbiomaterials.9b01585","article-title":"Gelator length precisely tunes supramolecular hydrogel stiffness and neuronal phenotype in 3D culture","volume":"6","author":"Godbe","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.trim.2026.102465_bb0235","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1529\/biophysj.108.132217","article-title":"Substrate modulus directs neural stem cell behavior","volume":"95","author":"Saha","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.trim.2026.102465_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-017-0080-5","article-title":"Modeling the behavior of human induced pluripotent stem cells seeded on melt electrospun scaffolds","volume":"11","author":"Hall","year":"2017","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.trim.2026.102465_bb0245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/acs.biomac.9b01319","article-title":"Laminin-inspired cell-instructive microenvironments for neural stem cells","volume":"21","author":"Barros","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.trim.2026.102465_bb0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2013.12.002","article-title":"Hybrid scaffold composed of hydrogel\/3D-framework and its application as a dopamine delivery system","volume":"175","author":"Kang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.trim.2026.102465_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1670649","article-title":"Mesenchymal stromal cell-laden hydrogels in tissue regeneration: insights from preclinical and clinical research","volume":"16","author":"Barbon","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.trim.2026.102465_bb0300","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1021\/acsami.4c15873","article-title":"Kidney-derived ECM hydrogels as cell delivery devices","volume":"17","author":"Rodrigues","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.trim.2026.102465_bb0305","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1039\/D4TB02722A","article-title":"A T1 MRI detectable hyaluronic acid hydrogel for in vivo tracking after intracerebral injection in stroke","volume":"13","author":"Said","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.trim.2026.102465_bb0310","article-title":"A biocompatible and injectable hydrogel to boost the efficacy of stem cells in neurodegenerative diseases treatment","volume":"282","author":"Ferreira","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0315","doi-asserted-by":"crossref","DOI":"10.1007\/s13770-025-00772-3","article-title":"Engineering mesenchymal stem cell-derived extracellular vesicles for the treatment of chronic kidney diseases","author":"Liao","year":"2026","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0255","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/molecules28052336","article-title":"Cell membrane biomimetic nanoparticles with potential in treatment of Alzheimer's disease","volume":"28","author":"Zhong","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.trim.2026.102465_bb0260","first-page":"2345","article-title":"Research progress of membrane biomimetic nanoparticles traversing the blood-brain barrier to treat brain diseases","volume":"59","author":"Liu","year":"2024","journal-title":"Yaoxue Xuebao"},{"key":"10.1016\/j.trim.2026.102465_bb0265","article-title":"Cell membrane-coated nanoparticles for neurodegenerative disorders management","volume":"651","author":"Thakur","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.trim.2026.102465_bb0270","first-page":"1122","article-title":"Biomimetic nanoparticles enhance recovery of movement disorders in Parkinson's disease by improving microglial mitochondrial homeostasis and suppressing neuroinflammation","volume":"17","author":"Li","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.trim.2026.102465_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206910","article-title":"Developing hypoimmunogenic human iPSC-derived oligodendrocyte progenitor cells as an off-the-shelf cell therapy for myelin disorders","volume":"10","author":"Feng","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0400","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03304-9","article-title":"Enhanced survival of hypoimmunogenic otic progenitors following intracochlear xenotransplantation: repercussions for stem cell therapy in hearing loss models","volume":"14","author":"Andrade da Silva","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.trim.2026.102465_bb0510","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.trim.2026.102465_bb0275","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcyt.2025.04.058","article-title":"Scaling up pluripotent stem cell-based therapies \u2013 considerations, current challenges and emerging technologies: perspectives from the ISCT emerging regenerative medicine working group","volume":"27","author":"Francis","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.trim.2026.102465_bb0280","series-title":"Standardisation in Cell and Tissue Engineering: Methods and Protocols","first-page":"219","article-title":"Commercial manufacture of cell therapies","author":"Wall","year":"2013"},{"key":"10.1016\/j.trim.2026.102465_bb0285","series-title":"Tissue Engineering and Regeneration in Dentistry: Current Strategies","first-page":"301","article-title":"Industrial translation requirements for manufacture of stem cell-derived and tissue-engineered products","author":"Wall","year":"2016"},{"key":"10.1016\/j.trim.2026.102465_bb0290","series-title":"Stem Cells in Veterinary Science","first-page":"65","article-title":"Biomaterials and scaffolds in stem cell therapy","author":"Bharti","year":"2022"},{"key":"10.1016\/j.trim.2026.102465_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129323","article-title":"Smart\/stimuli-responsive chitosan\/gelatin and other polymeric macromolecules natural hydrogels vs. synthetic hydrogels systems for brain tissue engineering: a state-of-the-art review","volume":"260","author":"El-Husseiny","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.trim.2026.102465_bb0325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.actbio.2021.11.038","article-title":"Bioactive injectable hydrogels for on demand molecule\/cell delivery and for tissue regeneration in the central nervous system","volume":"140","author":"Grimaudo","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.trim.2026.102465_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-025-10857-0","article-title":"Applications of gene editing and nanotechnology in stem cell-based therapies for human diseases","volume":"21","author":"Bolideei","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.trim.2026.102465_bb0335","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.rpor.2019.01.007","article-title":"Gene delivery methods and genome editing of human pluripotent stem cells","volume":"24","author":"Czerwi\u0144ska","year":"2019","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"10.1016\/j.trim.2026.102465_bb0340","first-page":"1","article-title":"Genome editing of hPSCs: recent progress in hPSC-based disease modeling for understanding disease mechanisms","volume":"182","author":"Choi","year":"2021","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0345","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1515\/revneuro-2015-0054","article-title":"Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease","volume":"27","author":"Cs\u00f6b\u00f6nyeiov\u00e1","year":"2016","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.trim.2026.102465_bb0485","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.trim.2026.102465_bb0490","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.trim.2026.102465_bb0495","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trim.2026.102465_bb0500","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0505","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trim.2026.102465_bb0350","article-title":"Stem cell-laden 3D bioprinting for osteoarthritis: orchestrating chondrogenic induction and inflammatory microenvironment modulation","volume":"68","author":"Niu","year":"2026","journal-title":"Colloids Interface Sci. Commun."},{"key":"10.1016\/j.trim.2026.102465_bb0355","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/ten.tea.2023.0255","article-title":"Immunomodulatory strategies for cartilage regeneration in osteoarthritis","volume":"30","author":"Kennedy","year":"2024","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.trim.2026.102465_bb0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11926-022-01061-x","article-title":"Engineering closed-loop, autoregulatory gene circuits for osteoarthritis cell-based therapies","volume":"24","author":"Coleman","year":"2022","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.trim.2026.102465_bb0365","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jcyt.2019.10.004","article-title":"Mesenchymal stem cells in the treatment of articular cartilage degeneration: new biological insights for an old-timer cell","volume":"21","author":"Colombini","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.trim.2026.102465_bb0370","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41565-024-01851-7","article-title":"Customizable virus-like particles deliver CRISPR\u2013Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy","volume":"20","author":"Ling","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.trim.2026.102465_bb0515","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.3860","article-title":"HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells","volume":"35","author":"Gornalusse","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.trim.2026.102465_bb0405","article-title":"CRISPR\/Cas genome editing for neurodegenerative diseases: mechanisms, therapeutic advances, and clinical prospects","volume":"104","author":"Pandya","year":"2026","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.trim.2026.102465_bb0410","first-page":"1","article-title":"Nanotechnology based CRISPR delivery platforms in therapeutic genome engineering","volume":"16","author":"Yadav","year":"2026","journal-title":"Int. J. Drug Deliv. Technol."},{"key":"10.1016\/j.trim.2026.102465_bb0415","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2478\/acb-2021-0008","article-title":"Recent findings on perinatal mesenchymal stem cells\u2014their possible application in current advanced medicine","volume":"9","author":"Sibiak","year":"2021","journal-title":"Med. J. Cell Biol."},{"key":"10.1016\/j.trim.2026.102465_bb0520","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2026.102465_bb0525","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.trim.2026.102465_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411810","article-title":"Hypoimmunogenic human pluripotent stem cells as a powerful tool for liver regenerative medicine","volume":"24","author":"Trionfini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2026.102465_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10751","article-title":"Early-phase clinical trials of bio-artificial organ technology: a systematic review of ethical issues","volume":"35","author":"de Jongh","year":"2022","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2026.102465_bb0530","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.stemcr.2021.05.012","article-title":"ISSCR guidelines for stem cell research and clinical translation: the 2021 update","volume":"16","author":"Lovell-Badge","year":"2021","journal-title":"Stem Cell Rep."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426001231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426001231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:50:45Z","timestamp":1792475445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426001231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":106,"alternative-id":["S0966327426001231"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102465","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging stem cell strategies for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102465"}}